184 Episodes

  1. EP 84: Mark Kotter, CEO, and Founder of bit.bio, on creating every cell type and kickstarting a cell therapy revolution

    Published: 01/09/2022
  2. EP 83: Daphne Koller, Founder & CEO of Insitro - Integrating machine learning and biology at scale to reimagine drug discovery

    Published: 11/08/2022
  3. EP 82: Lessons from the world's largest genomic datasets with Daniel MacArthur, Director of the Centre for Population Genomics.

    Published: 13/07/2022
  4. EP 81: Cracking the druggable genome with Dietrich Stephan, Founder and CEO of NeuBase Therapeutics

    Published: 29/06/2022
  5. EP 80: Rare disease genomics and the 'near-coding' genome with Nicky Whiffin, Group Leader at the Wellcome Centre for Human Genetics

    Published: 15/06/2022
  6. EP 79: The Unknown Causes of Kidney Disease Project with Michael Spigler, Vice President of Patient Support and Education at American Kidney Fund

    Published: 01/06/2022
  7. EP 78: From datasets to front-line healthcare; polygenic risk scores and genomic prediction with Prof Sir Peter Donnelly, CEO of Genomics PLC

    Published: 18/05/2022
  8. EP 77: The journey to novel gene therapies for hearing loss and balance disorders with Laurence Reid, CEO at Decibel Therapeutics

    Published: 04/05/2022
  9. EP 76: The UK Biobank Whole Genome Sequencing Project: building the future of genomics research with Dr Mark Effingham, Dr Kári Stefánsson and Professor Marylyn Ritchie

    Published: 20/04/2022
  10. EP 75: Participant engagement in genomics research, with Nathalie Kingston, Director of the NIHR BioResource

    Published: 06/04/2022
  11. EP 74: Biggest breakthroughs of 2021 with Personalized Medicine Podcast host, Oleksandr Yagensky

    Published: 19/12/2021
  12. EP 73: Ochre Bio: Building an in-silico liver model and addressing the impact and challenges of developing new treatments

    Published: 24/11/2021
  13. EP72: The DecodeME team on the challenges facing myalgic encephalomyelitis and chronic fatigue syndrome patients and the future of personalised treatments

    Published: 10/11/2021
  14. EP 71: Chief Medical Officer at LyGenesis, Professor Paulo Fontes, on the future of organ transplants

    Published: 29/10/2021
  15. EP 70: The University of Oxford's Professor Cecilia Lindgren: understanding complex disease through big data and team science

    Published: 14/10/2021
  16. EP 69: Chief Scientific Officer at Parkinson's Foundation, Dr James Beck, and Dr Ignacio Mata, Professor at the Cleveland Clinic, on the genetics of Parkinson’s disease and the future of precision tre

    Published: 24/09/2021
  17. EP 68: Dr Patrick Short features on GIANT’s Healthy Innovators Podcast and discusses the path to creating a successful startup in genomic medicine

    Published: 01/09/2021
  18. EP 67: Dr Anna Lewis from the Edmond J. Safra Center for Ethics at Harvard, on the biggest ethical questions in DNA sequencing and editing

    Published: 18/08/2021
  19. EP 66: Professor David Strain, Senior Clinical Lecturer at the University of Exeter Medical School, on the emergence of Long COVID, its impact and how research is vital for supporting patients

    Published: 04/08/2021
  20. EP 65: Dr Patrick Short guest features on The G Word podcast and discusses the power of translational research with CEO of Genomics England, Chris Wigley

    Published: 30/06/2021

6 / 10

Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com

Visit the podcast's native language site